Enovis (ENOV) Other Non-Current Assets (2010 - 2026)
Enovis' (ENOV) quarterly Other Non-Current Assets came in at $94.0 million in Q2 2026, up 8.33% year-on-year from $86.7 million in Q2 2025, and up 0.66% on a QoQ basis from $93.3 million in Q4 2025.
Enovis (ENOV) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Enovis (ENOV) has 17 years of Other Non-Current Assets data on file, last reported at $94.0 million in Q2 2026.
- On a quarterly basis, Other Non-Current Assets rose 8.33% year-over-year to $94.0 million in Q2 2026; TTM through Apr 2026 was $94.0 million, a 8.33% increase from a year earlier, with the FY2025 full-year figure at $93.3 million, up 5.15% from the prior year.
- Other Non-Current Assets for Q2 2026 stood at $94.0 million, up from $93.3 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for ENOV reached as high as $374.8 million in Q2 2022 and fell as low as $920000.0 in Q4 2025.
- Historically, Other Non-Current Assets has averaged $102.8 million across 5 years, with a median of $89.2 million in 2024.
- Across the five-year window, Other Non-Current Assets grew 12.41% in 2023 and tumbled 98.98% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $80.3 million in 2022, then rose by 12.41% to $90.3 million in 2023, then decreased by 1.64% to $88.8 million in 2024, then increased by 5.15% to $93.3 million in 2025, then advanced by 0.66% to $94.0 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $94.0 million in Q2 2026, $93.3 million in Q4 2025, and $920000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn | 93.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 93.96 Mn |
| Dec 31, 2025 | 93.35 Mn |
| Oct 3, 2025 | 920,000.00 |
| Jul 4, 2025 | 92.41 Mn |
| Apr 4, 2025 | 86.74 Mn |
| Dec 31, 2024 | 88.78 Mn |
| Sep 27, 2024 | 90.32 Mn |
| Jun 28, 2024 | 88.65 Mn |
| Mar 29, 2024 | 89.19 Mn |
| Dec 31, 2023 | 90.26 Mn |
| Sep 29, 2023 | 94.94 Mn |
| Jun 30, 2023 | 88.78 Mn |
| Mar 31, 2023 | 87.87 Mn |
| Dec 31, 2022 | 80.29 Mn |
| Apr 1, 2022 | 374.82 Mn |
| Dec 31, 2021 | 74.70 Mn |
| Oct 1, 2021 | 352.37 Mn |
| Jul 2, 2021 | 360.18 Mn |
| Apr 2, 2021 | 354.30 Mn |
| Dec 31, 2020 | 350.83 Mn |